PRKAA2 and diabetes mellitus: Another anti-aging and diabetes drug, metformin, primarily targets mitochondrial respiration, but also mediates longevity by regulating insulin-like growth factor (IGF-1) and AMP-activated protein kinase (AMPK; also known as PRKAA2) signaling (Menendez, 2020).